Pearls and pitfalls of clinical trial investigation: should I get involved in the drug development process?
The revolution in neurological therapeutics means that an increasing number of neurologists will have the opportunity to participate in a drug development process that is long and complicated. The opportunity provides challenges as well as rewards, and should be undertaken only after thoughtful review of the Clinical Investigator's Brochure and protocol. Key questions that the neurologist should address prior to participation are reviewed herein.
Chappell
A S
AS
Clinical Neurosciences, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285-0001, USA.
D002986:Clinical Trials as Topic / Q000592:standards*; D015507:Drugs, Investigational; D006801:Humans; D017387:Investigational New Drug Application; D009462:Neurology / Q000639:trends*; D011619:Psychotropic Drugs; D014481:United States
D015507:Drugs, Investigational; D011619:Psychotropic Drugs